Clinical Trial Update: Evaluation of S-600918 in Adults With Refractory Chronic Cough [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating S-600918 in adults with refractory chronic cough has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cough

Drugs mentioned

• S-600918

Snippet

Sponsor: Shionogi | Conditions: Chronic Cough | Phase 2 | Status: COMPLETED | Results posted: 2024-03-27